The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation.
The goal of this study is to create a data registry to capture clinical, pathologic, and molecular data/outcomes for patients with metastatic colorectal cancer who undergo live donor liver transplantation. Our primary outcome of interest was the OS and recurrence-free survival (RFS) of patients who underwent LDLT at our center.
Study Type
OBSERVATIONAL
Enrollment
25
living donor liver transplantation
University of Rochester Medical Center
Rochester, New York, United States
RECRUITINGpercentage of patients with recurrence free survival
RFS proportions to be calculated at 1, 3, and 5 years with Kaplan Meier analysis
Time frame: 5 years
percentage overall survival
OS proportions to be calculated at 1, 3, and 5 years with Kaplan Meier analysis
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.